Patients with leukaemia and other forms of haematological malignancy comprise a group at high risk for systemic forms of candidosis.' While many surveys have examined the prevalence and prevention of clinically important Candida infection in such patients, very few have studied their yeast flora in the absence of overt fungal infection. Most studies of this type have involved patient populations with a wide spectrum of malignant diseases. Only Tomoda et al specifically surveyed patients receiving anti-leukaemia chemotherapy2: they found higher faecal Candida concentrations among 56 such patients compared with healthy controls and identified the Candida species in 29 isolates.
This study was designed to examine the Candida species and C albicans biotypes isolated in routine samples from patients undergoing chemotherapy or bone marrow transplantation for haematological disease. By identifying and biotyping all yeast isolates received from such patients, it was hoped to determine longitudinal as well as cross sectional patterns ofyeast colonisation in this particular group of patients.
Patients and methods
The study group comprised 153 patients nursed in either a general ward, a 28 bed mixed haematology/ Accepted for publication 28 July 1989 chest diseases ward, or a general paediatrics ward. About 40% of treatment courses were undertaken in single rooms using protective isolation techniques. The period of the study spanned October 1985 to July 1986. The patients had various haematological malignancies, predominantly acute myeloblastic leukaemia, and were receiving induction/remission chemotherapy according to several different protocols. Nineteen patients underwent allogeneic bone marrow transplantation for acute leukaemia, chronic granulocytic leukaemia, lymphoma or aplastic anaemia, and four patients had autografts for acute lymphoblastic leukaemia.
Almost all patients received antifungal prophylaxis during their hospital stay with oral amphotericin B 500 mg four times a day and ketoconazole 200 mg twice a day. Ten patients received ketoconazole alone and seven were given itraconazole 100 mg daily. Nine patients received no antifungal prophylaxis. All patients were given colistin (1 5 x 106 units 12 hourly by mouth), neomycin (500 mg 12 hourly by mouth), and 1% povidone iodine mouth Washes (5 ml six hourly).
Routine microbiological screening entailed regular culture of oral or throat swabs and faeces on Sabouraud's glucose agar as well as on bacteriological culture media.
All cultures positive for yeast were stored at 4°C for two to eight weeks before they were processed for yeast 1259 Isolates from both the mouth and the faeces of an individual patient were obtained in 57 instances on the same date. In 35 of these instances the Candida species or C albicans biotype was the same in both specimens; in 18 the Candida species isolated were different, and in four the C albicans biotypes isolated differed between the oral and faecal isolates. Mixtures of Candida species or C albicans biotypes were obtained in 25 of the samples. Six of the oral samples contained C albicans plus another Candida sp; one contained C glabrata plus C parapsilosis; and one contained C albicans plus S cerevisiae. Two oral samples contained two C albicans biotypes. Among the faecal samples, C albicans plus another Candida sp was found on six occasions, C albicans plus S cerevisiae once, and two C albicans biotypes once. The remaining instances of mixed populations occurred in two samples ofsputum, a vaginal swab, a nasal swab, a perineal swab and an eye sample.
YEAST FLORA IN INDIVIDUAL PATIENTS Table 3 gives details of isolates obtained in 12 patients from whom at least 12 yeast positive samples were obtained. Except where stated below, all 12 patients received prophylactic cover with amphotericin B plus ketoconazole. The results are presented in detail for these patients because they convey more clearly than any analysis the often complex nature of the findings of this survey. They show that for most patients a consistent yeast microflora was harboured at a given site. Case 1 who received no antifungal prophylaxis, was consistently colonised with C tropicalis, except for a single occasion when C glabrata was isolated from a stool sample. Case 2 was colonised orally and faecally mainly with C albicans biotypes 015 and 215 (consensus biotype 215) on three separate admissions to the ward. C tropicalis was also isolated frequently from oral samples during the first admission, and Cglabrata was present in several faecal samples during admissions 1 and 3.
Case 3 was colonised with Candida mainly in faecal samples on three separate admissions. C glabrata was the species isolated most often, but C krusei was encountered in some oral samples during the first two admissions, and C albicans was isolated from single oral and faecal samples during the first admission. This patient received ketoconazole alone for antifungal prophylaxis but amphotericin B was added in subsequent admissions. Case 4 was also colonised with Candida mainly in faecal samples, but the flora was complex. A flora of C albicans (consensus biotype 055) was present during the first three weeks of this patient's first admission, but this species was replaced first with a mixed flora of C krusei and S cerevisiae, then with C glabrata and S cerevisiae, a combination that persisted through the patient's second and third hospital admissions.
Case 5 was positive for Candida primarily in the oral cavity, and his C albicans flora persisted through five hospital admissions. The C albicans biotype patterns varied from sample to sample in this patient, but all isolates were within two test differences of the consensus type 353. Case 6 was colonised with C albicans consensus biotype 345 in oral and faecal samples during three admissions. Her prophylactic antifungal treatment varied between admissions: itraconazole was used alone during the first admission; amphotericin B plus ketoconazole in subsequent admissions. Case 7 similarly retained a C albicans flora (consensus type 353) throughout four hospital admissions, although in this patient occasional faecal samples yielded Cglabrata during the first two admissions.
Odds, Kibbler, Walker, Bhamra, Prentice, Noone The 12 patients included in the table were those for whom 12 or more yeast isolations were recorded in the study. Numbers of occasions on which each species or C albicans biotype were isolated are given in parentheses.
Case 8 is an example of a case in which the C albicans biotypes isolated seemed to vary considerably ( 345 and 357. In addition to these three C albicans types, S cerevisiae was recovered from one oral and one sputum specimen. Case 9 seems to have acquired a C albicans flora between his first and second hospital admissions. The three different yeast species recovered from his faeces during the first admission were not isolated at all during admissions 2 and 3. C albicans types 557 and 077, which were isolated from this patient's nose and perineum, respectively, during the first admission, bore no resemblance to the C albicans consensus type 146 that was isolated repeatedly during appearance of any yeast species or C albicans biotype different from that or those encountered in the earliest yeast positive sample. On this basis it was evident that changes in the yeast flora occurred significantly more often in faecal samples (57% showed some change) than in oral samples (29% showed some change); x2 test, p < 0 02 (table 4) . In faecal samples the changes in flora occurred significantly more often after 14 days ofyeast colonisation than within a 14 day period (table   4 ; X2 test, p < 0-01).
Of 49 patient admissions in which the positive oral or faecal sample contained C albicans, a new yeast species was subsequently found in only 11 (22%); in 33 patient admissions where the first yeast isolated was a species other than Calbicans, a new species subsequently appeared in 18 (55%) (x2 test, p < 0.02). C albicans and C glabrata were the two species which seemed to be acquired most commonly as replacement or additional yeast flora among the patients studied (table 5) . There were no statistical associations between changes in the yeast flora and the nature of antifungal prophylaxis used or the time of species change subsequent to the time of hospital admission.
Twenty five of the patients were admitted to the ward on at least two separate occasions during the study. For 15 of these patients there were at least two yeast positive samples from a single anatomical source within each admission, so that changes in flora between admissions could be assessed. Only three of the 15 patients showed any change in their yeast flora that could be interpreted as a change between admissions; the other 12 retained essentially the same yeast flora, sometimes throughout three or more admissions (table 3) . The three flora changes were all of a different nature. One patient whose faecal isolates were C glabrata and S cerevisiae on the first admission consistently carried C albicans type 146 on the second admission (case 9, table 3). One patient from whom only C albicans was isolated from faeces during the first admission had C glabrata present as well as C albicans in faeces during the second admission (case 10). Finally, case 12, with a single oral swab positive for Cfamata during the first admission, was colonised group.bmj.com on May 29, 2017 -Published by http://jcp.bmj.com/ Downloaded from Carriage of Candida sp in immunocompromised patients with haematological disease In patients from whom more than one yeast species was isolated subsequent to the first sample, each new species is counted separately.
orally with C krusei and C albicans during the second admission.
Discussion
As far as we know this study is the first broadly based study ofcommensal yeast colonisation among patients with haematological disease. Yeast species found among such patients occur in a complex manner and faecal samples are more likely than oral samples to show changes in the yeast species present during a patient's hospital stay. The spectrum of yeast species isolated overall from these patients can be compared with that found among cancer patients of all types. Kiehn et al found that C albicans accounted for 73% of oral yeast isolates and 72% of faecal yeast isolates from their cancer patients. 6 Tomoda et al found this species in 69% of faecal isolates from their cancer patients.2 The figures for oral and faecal yeast species in our survey showed prevalences of C albicans of 64% and 45%, respectively, which indicates a lower preponderance of C albicans among the patients with leukaemia than among other cancer patients. Whether this difference is specifically related to haematological disease or to other factors such as the selective pressures of antifungal prophylaxis as used in our patients is not known.
A yeast flora persisted among many patients despite the use ofprophylactic, orally administered antifungal drugs. No antifungal agent has yet been shown to be capable of eliminating the commensal yeast flora in patients with leukaemia, although agents such as amphotericin B and ketoconazole seem to reduce the incidence of life threatening systemic Candida infections among this population. ' Both the value and the inadequacies of the biotyping method used to differentiate C albicans strains in the present study have been shown very plainly. Indeed, this is the most substantial study in which C albicans biotyping has been applied blind to a very large number of yeast isolates over a long period of time. The data in table 3 confirm the inherent reliability ofthe method, as in four ofthe patients (case 2, 4, 5 and 9) a highly acceptable consistency in biotypes was found over a period of time. Similarly consistent biotyping results were found in other patients who harboured C albicans over long periods but for whom the total number of yeast isolates in the study was fewer than for those included in table 3. On the other hand, results showing wider variations in biotype data were obtained longitudinally in cases 6, 7, 8, 9, and 10 although even among most of these patients there was a tendency towards a consistent underlying biotype pattern. Results from the Candida biotyping tests used in this study are known to be highly vulnerable to technical performance variables, particularly to variance in inoculum size,38 so the use of "consensus" biotype results determined by computer for each patient avoids overinterpretation of apparent changes in C albicans. On this basis it seems that patients with leukaemia change their C albicans biotype less often than they change the species of yeast with which they are colonised. Biotype results cannot be reliably compared between studies,8 so no attempt is made here to relate the C albicans biotypes found in this patient group with those in other surveys.
We can only speculate as to why the faecal yeast flora seems-to change more often than the oral yeast flora among the patients studied. Because it seems that a site colonised with C albicans is significantly less likely to undergo a change in commensal yeast species than a site harbouring another species, the reduced initial prevalence of C albicans in the faeces of our patients seems to render the lower bowel more prone to colonisation by other yeasts. Certainly, C albicans adheres better than other yeast species to epithelial surfaces,' which may explain the comparative resilience of intestinal sites occupied by C albicans to recolonisation.
The relative consistency of our patients' commensal yeast flora, both within and between admissions to the haematology wards, provides little evidence for cross contamination of the patients with yeasts from the environment, staff, or other patients. Apparent outbreaks of systemic Candida infection have been documented in some intensive care units910 and a neonatal special care unit," though not yet in specialist leukaemia wards. The results of our extensive survey suggest such outbreaks of candidosis result from the chance introduction into these closed units of strains with an unusually high propensity to colonise the patients, and that they do not represent an ever present hazard from an inherent tendency of "ward" strains of Candida to cross infect patients readily. 
